Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Search Results for: pathology

ASCP’s New Pathology Analytics Platform Aims to Improve Workflows

CEO SUMMARY: During a recent webinar, Sachin Gupta, PhD, of the American Society for Clinical Pathology demonstrated the organization’s new Performance and Diagnostics Insights (PDI)  analytics and benchmarking platform. PDI provides extensive reports based on near real-time data from laboratory information systems and other sources. The University of Nebraska Medical Center is among the early […]

To access this post, you must purchase The Dark Report.

ASCP’s New Pathology Analytics Platform Aims to Improve Workflows Read More »

Consortium Brings Open- Source Vision to Digital Pathology

CEO SUMMARY: American health technology company Tempus AI, in concert with two academic medical centers, recently formed a consortium that will offer a free, open-source digital pathology platform. The organizations hope to develop open standards that will increase the interoperability of digital pathology systems while also making the technology more accessible for resource-strapped pathology practices.

To access this post, you must purchase The Dark Report.

Consortium Brings Open- Source Vision to Digital Pathology Read More »

Digital Pathology’s Next Wave May Be in Precision Medicine

We’ve noted before that the adoption of digital pathology has not been as swift or strong as originally predicted. Many factors contribute to that concern. This topic came up in a recent interview The Dark Report conducted with Imogen Fitt, principal analyst at Signify Research, which released its 2025 Digital Pathology World Report in November.

To access this post, you must purchase The Dark Report.

Digital Pathology’s Next Wave May Be in Precision Medicine Read More »

Tracking the Chain of Custody in Histopathology Labs

Despite increasing adoption of digital pathology systems, many histopathology laboratories remain mired in manual workflows in the critical pre-analytical phase, as specimens are collected and processed into slides. Such workflows are not only inefficient but also susceptible to human error and tissue degradation, which increases the odds of inaccurate diagnoses. They also create safety hazards

To access this post, you must purchase The Dark Report.

Tracking the Chain of Custody in Histopathology Labs Read More »

Pathology Lab Opportunities for Biopharma Collaboration

As anatomic pathology laboratories face declining reimbursements and other challenges to their bottom lines, one possible solution could involve collaboration with biopharmaceutical companies. But what exactly are drug companies looking for, and how can labs forge those relationships? Three biopharma executives addressed these questions during a session at the 2025 Executive War College. “The needs

To access this post, you must purchase The Dark Report.

Pathology Lab Opportunities for Biopharma Collaboration Read More »

NYU Langone Rolls Out Digital Pathology in One Year

During an ambitious one-year project, NYU Langone Health implemented full-scale digital pathology. Although the initiative was large, a key organizer insists that smaller diagnostic labs can use some of the same approaches. Two big lessons to convey: Document the gritty details of pathology workflows with the IT team and push technology vendors to help a

To access this post, you must purchase The Dark Report.

NYU Langone Rolls Out Digital Pathology in One Year Read More »

Pathology Journals Not Immune to Questionable Studies

As we recently reported, scientific fraud is more prevalent than many people in the science community would like to admit. The “publish or perish” mindset in academia has led to a proliferation of questionable and even fabricated papers in peer-reviewed journals. But to what extent do these problems apply to pathology and laboratory medicine? Quite

To access this post, you must purchase The Dark Report.

Pathology Journals Not Immune to Questionable Studies Read More »

Lumea’s Digital Pathology Success Lands It on Inc. 5000

Digital pathology company Lumea was perhaps the most notable entry from the clinical laboratory world to make it onto the Inc. 5000 list of the fastest growing private companies in America in 2025. Lumea placed mid-pack at No. 2,468  in the ranking. Editors at Inc. noted that the company has enjoyed 173% growth over the

To access this post, you must purchase The Dark Report.

Lumea’s Digital Pathology Success Lands It on Inc. 5000 Read More »

Deal Offers Signals about the Future of Digital Pathology

THE DIGITAL PATHOLOGY MARKET IS AT AN INFLECTION POINT, AND TEMPUS’ RECENT $81.25 MILLION ACQUISITION OF PAIGE underscores both the challenges and opportunities ahead. While the pandemic temporarily accelerated digital pathology adoption, with vendors raising large sums on the promise of artificial intelligence (AI)-powered diagnostics and remote workflows, the realities of cost, reimbursement hurdles, workflow

To access this post, you must purchase The Dark Report.

Deal Offers Signals about the Future of Digital Pathology Read More »

2026 EXECUTIVE WAR COLLEGE CONFERENCE ON LABORATORY & PATHOLOGY MANAGEMENT

Learn what’s new, what’s working, and how to lead your lab to success.  The 2026 Executive War College is your place to learn, network, and succeed. See, hear, and meet leaders of the nation’s most innovative labs as they share how they add value to improve patient outcomes while encouraging health insurers to pay them

2026 EXECUTIVE WAR COLLEGE CONFERENCE ON LABORATORY & PATHOLOGY MANAGEMENT Read More »

;